Estrella Immunopharma Statistics

Total Valuation

ESLA has a market cap or net worth of $34.72 million. The enterprise value is $33.81 million.

Market Cap	34.72M
Enterprise Value	33.81M

Important Dates

The last earnings date was Wednesday, May 14, 2025, after market close.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

ESLA has 36.17 million shares outstanding. The number of shares has increased by 255.55% in one year.

Current Share Class	36.17M
Shares Outstanding	36.17M
Shares Change (YoY)	+255.55%
Shares Change (QoQ)	-0.87%
Owned by Insiders (%)	2.70%
Owned by Institutions (%)	1.70%
Float	9.91M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	241.75
P/TBV Ratio	241.56
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.55, with a Debt / Equity ratio of 0.03.

Current Ratio	0.55
Quick Ratio	0.31
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-6,160.07%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, ESLA has paid $126 in taxes.

Income Tax	126
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +3.73% in the last 52 weeks. The beta is 0.37, so ESLA's price volatility has been lower than the market average.

Beta (5Y)	0.37
52-Week Price Change	+3.73%
50-Day Moving Average	0.98
200-Day Moving Average	1.03
Relative Strength Index (RSI)	46.77
Average Volume (20 Days)	512,636

Short Selling Information

The latest short interest is 11,541, so 0.03% of the outstanding shares have been sold short.

Short Interest	11,541
Short Previous Month	2,743
Short % of Shares Out	0.03%
Short % of Float	0.12%
Short Ratio (days to cover)	0.54

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-8.85M
Pretax Income	-6.09M
Net Income	-8.85M
EBITDA	n/a
EBIT	-8.85M
Earnings Per Share (EPS)	-$0.24

Full Income Statement

Balance Sheet

The company has $916,916 in cash and $4,000 in debt, giving a net cash position of $912,916 or $0.03 per share.

Cash & Cash Equivalents	916,916
Total Debt	4,000
Net Cash	912,916
Net Cash Per Share	$0.03
Equity (Book Value)	143,731
Book Value Per Share	0.00
Working Capital	-1.36M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-6.23M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ESLA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-255.55%
Shareholder Yield	-255.55%
Earnings Yield	-25.50%
FCF Yield	n/a

Analyst Forecast

The average price target for ESLA is $16.00, which is 1,566.67% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$16.00
Price Target Difference	1,566.67%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	12.35%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1